165 related articles for article (PubMed ID: 35725370)
1. Identification of Helicobacter pylori-related gastric cancer risk using serological gastritis markers and endoscopic findings: a large-scale retrospective cohort study.
Nagasaki N; Ito M; Boda T; Kotachi T; Takigawa H; Oka S; Tanaka S
BMC Gastroenterol; 2022 Jun; 22(1):299. PubMed ID: 35725370
[TBL] [Abstract][Full Text] [Related]
2. [Diagnostic Value of Serum Pepsinogen Ⅰ/Pepsinogen Ⅱ Combined with Tumor Markers for
Wang SS; Guo ZP; Zhao XY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Jan; 54(1):186-191. PubMed ID: 36647665
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic performance of the normal range of gastrin calculated using strict criteria based on a combination of serum markers and pathological evaluation for detecting gastritis: a retrospective study.
Nagasaki N; Takigawa H; Ito M; Boda T; Kotachi T; Hayashi R; Yuge R; Urabe Y; Oka S; Tanaka S
BMC Gastroenterol; 2023 May; 23(1):167. PubMed ID: 37210509
[TBL] [Abstract][Full Text] [Related]
4. Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels - "ABC method".
Miki K
Proc Jpn Acad Ser B Phys Biol Sci; 2011; 87(7):405-14. PubMed ID: 21785258
[TBL] [Abstract][Full Text] [Related]
5. Endoscopic evaluation by the Kyoto classification of gastritis combined with serum anti-Helicobacter pylori antibody testing reliably risk-stratifies subjects in a population-based gastric cancer screening program.
Hirai R; Hirai M; Otsuka M; Mitsuhashi T; Shimodate Y; Mouri H; Matsueda K; Yamamoto H; Mizuno M
J Gastroenterol; 2023 Sep; 58(9):848-855. PubMed ID: 37340218
[TBL] [Abstract][Full Text] [Related]
6. A retrospective study assessing the acceleration effect of type I Helicobacter pylori infection on the progress of atrophic gastritis.
Liu W; Tian J; Hui W; Kong W; Feng Y; Si J; Gao F
Sci Rep; 2021 Feb; 11(1):4143. PubMed ID: 33603125
[TBL] [Abstract][Full Text] [Related]
7. Serological Biomarker Panel in Diagnosis of Atrophic Gastritis and
Koivurova OP; Koskela R; Blomster T; Ala-Rämi A; Lumme H; Kettunen O; Hukkanen J; Karttunen TJ; Mäkinen M; Ronkainen J; Syrjänen K
Anticancer Res; 2021 Nov; 41(11):5527-5537. PubMed ID: 34732423
[TBL] [Abstract][Full Text] [Related]
8. Human gastric cancer risk screening: From rat pepsinogen studies to the ABC method.
Furihata C
Proc Jpn Acad Ser B Phys Biol Sci; 2021; 97(8):462-478. PubMed ID: 34629355
[TBL] [Abstract][Full Text] [Related]
9. [A comparative study of new gastric cancer screening scoring system and new ABC method for screening gastric cancer and precancerous lesions].
Wang XT; Ji ZZ; Han F; Lyu B
Zhonghua Nei Ke Za Zhi; 2021 Mar; 60(3):227-232. PubMed ID: 33663171
[No Abstract] [Full Text] [Related]
10. Utilization of an Automated Latex Agglutination Turbidity Assay for Assessing Gastric Mucosal Alteration during
Khangai A; Akada J; Saruuljavkhlan B; Gantuya B; Azzaya D; Oyuntsetseg K; Davaadorj D; Uchida T; Matsumoto T; Yamaoka Y
Gut Liver; 2024 Jan; 18(1):60-69. PubMed ID: 37720994
[TBL] [Abstract][Full Text] [Related]
11. No significant association between non-Helicobacter pylori Helicobacter infection with gastritis-related indices and gastric cancer.
Abuduwaili M; Takigawa H; Yuge R; Teshima H; Kotachi T; Urabe Y; Ito M; Sentani K; Oue N; Oka S; Kitadai Y; Tanaka S
Am J Med Sci; 2023 Dec; 366(6):421-429. PubMed ID: 37660992
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis by combination of endoscopic findings helps differentiate non-Helicobacter pylori Helicobacter-infected gastritis from Helicobacter pylori-infected gastritis.
Okamura T; Iwaya Y; Nagaya T; Horiuchi K; Negishi T; Ota H; Umemura T
Helicobacter; 2024; 29(2):e13070. PubMed ID: 38514917
[TBL] [Abstract][Full Text] [Related]
13. A case of nodular gastritis progression to autoimmune gastritis after 10 years of Helicobacter pylori eradication.
Sumi N; Haruma K; Inoue K; Hisamoto N; Mabe K; Sasai T; Ichiba T; Ayaki M; Manabe N; Takao T
Clin J Gastroenterol; 2024 Apr; 17(2):216-221. PubMed ID: 38072907
[TBL] [Abstract][Full Text] [Related]
14. Smoking history and severe atrophic gastritis assessed by pepsinogen are risk factors for the prevalence of synchronous gastric cancers in patients with gastric endoscopic submucosal dissection: a multicenter prospective cohort study.
Hatta W; Koike T; Asonuma S; Okata H; Uno K; Oikawa T; Iwai W; Yonechi M; Fukushi D; Kayaba S; Kikuchi R; Ohyauchi M; Fushiya J; Maejima R; Abe Y; Kawamura M; Honda J; Kondo Y; Dairaku N; Norita K; Watanabe K; Takahashi K; Echigo H; Abe Y; Endo H; Okata T; Hoshi T; Nakamura T; Nakaya N; Iijima K; Masamune A;
J Gastroenterol; 2023 May; 58(5):433-443. PubMed ID: 36786863
[TBL] [Abstract][Full Text] [Related]
15. A Predictive Model of Noncardia Gastric Adenocarcinoma Risk Using Antibody Response to Helicobacter pylori Proteins and Pepsinogen.
Murphy JD; Olshan AF; Lin FC; Troester MA; Nichols HB; Butt J; Qiao YL; Abnet CC; Inoue M; Tsugane S; Epplein M
Cancer Epidemiol Biomarkers Prev; 2022 Apr; 31(4):811-820. PubMed ID: 35131882
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune Atrophic Gastritis: The Role of miRNA in Relation to
Zingone F; Pilotto V; Cardin R; Maddalo G; Orlando C; Fassan M; Marsilio I; Collesei E; Pelizzaro F; Farinati F
Front Immunol; 2022; 13():930989. PubMed ID: 35941891
[TBL] [Abstract][Full Text] [Related]
17. Helicobacter pylori Antibody Titer and Gastric Cancer Screening.
Kishikawa H; Kimura K; Takarabe S; Kaida S; Nishida J
Dis Markers; 2015; 2015():156719. PubMed ID: 26494936
[TBL] [Abstract][Full Text] [Related]
18. Serum Pepsinogen as a Biomarker for Gastric Cancer in the United States: A Nested Case-Control Study Using the PLCO Cancer Screening Trial Data.
In H; Sarkar S; Ward J; Friedmann P; Parides M; Yang J; Epplein M
Cancer Epidemiol Biomarkers Prev; 2022 Jul; 31(7):1426-1432. PubMed ID: 35534235
[TBL] [Abstract][Full Text] [Related]
19. Appropriateness of Proton Pump Inhibitor Prescription Evaluated by Using Serological Markers.
Russo M; Rodriguez-Castro KI; Franceschi M; Ferronato A; Panozzo MP; Brozzi L; Di Mario F; Crafa P; Brandimarte G; Tursi A
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768710
[TBL] [Abstract][Full Text] [Related]
20. DO HELICOBACTER PYLORI INFECTION AND ERADICATION THERAPY STATUS INFLUENCE WEIGHT LOSS OUTCOMES AND ENDOSCOPIC FINDINGS AFTER ROUX-EN-Y GASTRIC BYPASS?A HISTORICAL COHORT STUDY.
Sia GB; Gestic MA; Utrini MP; Chaim FDM; Chaim EA; Cazzo E
Arq Gastroenterol; 2023; 60(1):57-64. PubMed ID: 37194781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
